Latest Breaking News On - Ramon varcoe - Page 4 : comparemela.com

SurModics (SRDX) Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium

SurModics (SRDX) Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandNew yorkUnited statesRamon varcoeSundance sirolimusAndrew holdenSurmodics incCompany sundanceAnnual symposiumEndovascular issuesSwing trialMajor adverse limb eventRutherford clinical classificationProfessor ramon varcoeProfessor andrew holden

Surmodics, Inc : 6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe

Sundance Sirolimus DCB demonstrates lowest binary restenosis at 6 months compared to relevant BTK clinical trials Excellent safety profile observed with no major amputations and low rates of MAE Surmodics

United statesEden prairieNew zealandRamon varcoeAndrew holdenSundance sirolimusTim arensSurmodics incAmputation prevention symposiumLate lumen lossProfessor ramon varcoeSwing trialProfessor andrew holdenSundance sirolimus drug coatedSundance sirolimus drug coated balloonAnnual report

6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe

Sundance™ Sirolimus DCB demonstrates lowest binary restenosis at 6 months compared to relevant BTK clinical trialsExcellent safety profile observed with no major amputations and low rates of MAEEDEN PRAIRIE, Minn. (BUSINESS WIRE) #Acquisition Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and.

United statesEden prairieNew zealandRamon varcoeAndrew holdenSundance sirolimusSurmodics incAmputation prevention symposiumLate lumen lossProfessor ramon varcoeSwing trialProfessor andrew holdenSirolimus drug coatedSundance sirolimus drug coated balloonAnnual report

SurModics (SRDX) Announces 6-Month Data from SWING BTK First-in-Human Trial Presented at AMP Europe

SurModics (SRDX) Announces 6-Month Data from SWING BTK First-in-Human Trial Presented at AMP Europe
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandRamon varcoeSundance sirolimusAndrew holdenSurmodics incAmputation prevention symposiumLate lumen lossProfessor ramon varcoeSwing trialProfessor andrew holden

6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe

35-subject trial evaluating safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated BalloonEDEN PRAIRIE, Minn. (BUSINESS WIRE) #Acquisition Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that Professor.

New zealandEden prairieUnited statesNew south walesRamon varcoeSurmodic sundanceAndrew holdenSurmodics incSirolimus drug coatedProfessor ramon varcoeAmputation prevention symposiumMain hallWales hospitalOperating theatresSouth east sydney healthNorthern region interventional radiology service